comparemela.com

Latest Breaking News On - Prnewswire lipocine inc - Page 4 : comparemela.com

Lipocine to Present at H C Wainwright Annual Neuropsychiatry Virtual Conference

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its.

Mahesh patelPrnewswire lipocine incCentral nervous systemChief executive officerAnnual neuropsychiatry virtual conferenceLipocine incHealth care amp hospitalsMedical pharmaceuticals

Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine s Oral Candidate for Rapid Relief of Depression

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), today announced positive topline results from a pilot clinical PK bridge study of LPCN 1154 (oral brexanolone).

United statesMahesh patelPrnewswire lipocine incDrug administrationCentral nervous systemPostpartum depressionLipocine inc

First Subject Dosed in the Clinical Bridge Study with Lipocine Depression Candidate, LPCN 1154

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its.

United statesMahesh patelDrug administrationLipocine incPrnewswire lipocine incCentral nervous systemLipocine inc

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2022

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System ("CNS") disorders by leveraging its.

Mahesh patelGeorge nomikosSpyros papapetropoulosPrnewswire lipocine incLipocine incCentral nervous systemLead directorChief medicalMonths endedPrivate securities litigation reform actConsolidated statementsMonths ended septemberLipocine inc

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2022

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System ("CNS") disorders by leveraging its.

Mahesh patelGeorge nomikosSpyros papapetropoulosPrnewswire lipocine incLipocine incCentral nervous systemLead directorChief medicalMonths endedPrivate securities litigation reform actConsolidated statementsMonths ended september

vimarsana © 2020. All Rights Reserved.